🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Demonstrate the relationship between DD-cfDNA levels and HLA antibodies in ...
Status
Recruiting
Location
Baptist Health Institute for Research and Innovation
Start Date
2021-06-01
Trial ID
NCT04707872
Treatments Being Tested
RATIONALE: Studying samples of blood and tissue from patients at risk of ca...
Status
Completed
Location
Multiple Locations
Start Date
2003-06
Trial ID
NCT00611000
RATIONALE: Studying samples of tumor tissue from patients with cancer in th...
Status
Completed
Location
Multiple Locations
Start Date
2006-05
Trial ID
NCT00899418
RATIONALE: Drugs used in chemotherapy work in different ways to stop the gr...
Status
Completed
Location
Basingstoke and North Hampshire NHS Foundation Trust
Start Date
2006-08
Trial ID
NCT00454480
Treatments Being Tested
RATIONALE: Studying samples of blood and tissue from patients with cancer i...
Status
Completed
Location
Multiple Locations
Start Date
2010-04
Trial ID
NCT01139983
RATIONALE: Everolimus may stop the growth of cancer cells by blocking some ...
Status
Completed
Location
Mayo Clinic in Arizona
Start Date
2011-01-10
Trial ID
NCT01075321
This research trial studies biomarkers in predicting treatment response in ...
Status
Not Yet Recruiting
Location
National Cancer Institute of Canada Clinical Trials Group
Start Date
2012-05
Trial ID
NCT01595074
Treatments Being Tested
RATIONALE: Studying samples of blood and tumor tissue from patients with ca...
Status
Terminated
Location
Unversity of Nebraska Medical Center
Start Date
2004-04-15
Trial ID
NCT00665457
Treatments Being Tested
RATIONALE: Drugs used in chemotherapy, such as decitabine, work in differen...
Status
Completed
Location
Memorial Sloan Kettering Cancer Center
Start Date
2006-07
Trial ID
NCT00382200
The goal of the trial is the early detection of cardiotoxicity in patients ...
Status
Recruiting
Location
Robert Bosch Gesellschaft für Medizinische Forschung mbH
Start Date
2026-03-04
Trial ID
NCT07528586